Multivariate analysis further showed that increased TEX signature expression significantly associated with decreased overall survival and more so than patient age, tumor grade, tumor size, or even Oncotype DX BRS in premenopausal OncDXint patients (Figure 7F). This evidence concerns the gene TEX46 and neoplasm.